MRX DEADLINE: Rosen urges Marex Group plc investors to act before Dec. 8, 2025

Global investor‑rights firm Rosen Law Firm on Nov. 29, 2025 issued a notice to investors who bought securities of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025 (the “Class Period”), reminding them of a looming deadline to join a proposed class‑action lawsuit. Under the proposed action, investors who purchased Marex shares during that period may be eligible for compensation — with no upfront cost — via a contingency‑fee arrangement. If you wish to serve as lead plaintiff (i.e. a representative for the class), you must file a motion with the Court no later than December 8, 2025. The lawsuit alleges that during the Class Period, Marex made materially false or misleading statements — or failed to disclose key information — including that: the company sold over‑the‑counter financial instruments to itself; there were serious inconsistencies between the financial statements of Marex’s subsidiaries and related parties (e.g. intercompany receivables and loans), making the financials unreliable; as a result, Marex’s public statements about its operations and prospects were misleading or lacked a reasonable basis. When the undisclosed truths came to light, the firm claims that many investors suffered financial damages. If you bought Marex securities during the Class Period and want to participate — whether as a class member or as lead plaintiff — the Rosen Law Firm encourages you to submit a form on their website, call their toll‑free number, or email them for more information before the December 8 deadline. #Marex #ClassAction #InvestorAlert #RosenLawFirm #SlimScan #GrowthStocks #CANSLIM